Research on diabetes and its complications. Covers glucose prediction, nerve pain, weight-loss drugs, insulin access, and diabetes management.
A cross-sectional study found associations between HbA1c levels and modern diabetes technologies and insulin accessibility. Efforts to ensure universal accessibility are crucial to reduce global inequities in glycemic outcomes for children with type 1 diabetes.
Researchers at Wayne State University are developing an ultra-rapid insulin designed to mimic the human pancreas, aiming to improve glycemic control and reduce disease management burden. The project has the potential to create fully automated systems, enabling patients to manage their condition with fewer interruptions.
The Pennington Biomedical Research Center has opened a new Endocrinology and Diabetes Clinic in Baton Rouge, providing specialized care for patients managing diabetes and endocrine disorders. The clinic is led by Dr. Timothy Gilbert, who brings nearly 20 years of private practice experience to the region.
Researchers at Boston University School of Medicine found that tiny particles in the blood, known as exosomes, can reprogram immune cells inside tumors making them weaker and allowing the cancer to grow and spread more easily. The study provides new insights into why people with type 2 diabetes have worse breast cancer outcomes.
A Mediterranean-style diet, along with reduced caloric intake and moderate physical activity, has been shown to lower the risk of type 2 diabetes by 31%. The study found that participants in the intervention group lost an average of 3.3 kilograms and reduced their waist circumference by 3.6 centimeters.
A new national survey of over 580 school nurses and healthcare providers has identified critical barriers to implementing the ADA's DMMP in schools. The updated DMMP aims to streamline communication and provide greater customization for modern devices, enhancing safety, equity, and health outcomes for students with diabetes.
A large Spanish multicenter clinical trial found that a calorie-reduced Mediterranean diet combined with moderate exercise reduces type 2 diabetes risk by 31%. The intervention group also lost weight and reduced waist circumference, preventing approximately three in every 100 participants from developing the disease.
Researchers found that a molecule produced by gut bacteria can cause inflammation, scarring and fibrosis in the kidneys, a major complication of diabetes. Corisin, a small peptide, attaches to albumin in the blood and targets the delicate kidney structures, accelerating aging and cell death.
Research highlights preventable harms of intensive diabetes and hypertension treatment in frail older adults, calling for personalized care approaches that prioritize patient safety. Guidelines recommend cautious individualized care, but complications remain alarmingly common.
Researchers have created a wearable system that combines drug delivery, electrical stimulation, and continuous monitoring to treat diabetic foot ulcers. The microneedle platform anchors securely into the skin and adjusts therapy in real-time to prevent severe tissue damage.
Researchers developed a first-trimester blood test that accurately predicts gestational diabetes risk, using just seven biomarkers. The test's strong ability to distinguish high-risk from low-risk pregnancies could enable early interventions and reduce long-term health burdens.
Experts recommend SGLT-2 and GLP-1 diabetes drugs for adults with high cardiovascular and kidney risk, but not those at low risk. The guidelines emphasize weight loss alongside medication for adults with obesity.
An ethnobotanist from the Pataxó Hã-Hã-Hãi Indigenous Land in Brazil has revived ancestral healing knowledge to treat diseases like parasitic worms, diabetes, and hypertension. He discovered 43 medicinal plants used for these diseases, with 79% consistent with recent scientific literature.
Scientists have developed a monoclonal antibody to combat life-threatening inflammatory diseases like sepsis and ARDS. The antibody shows promise in blocking the immune system's hyperactive response and restoring healthy function without unwanted side effects.
Researchers at City of Hope are investigating how wearable devices can detect and prevent long-term health risks in childhood cancer survivors. Yue Liao, a UT Arlington expert, is contributing to the review article, highlighting the potential of digital health tools to monitor daily fluctuations and behavior.
A rapid increase in diabetes technology adoption led to improved glycemic control among type 1 diabetes patients, yet racial and socioeconomic disparities persisted. Notable racial and ethnic differences grew over time, highlighting the need for targeted interventions.
Researchers at Cornell University developed an implant system that can treat Type 1 diabetes by supplying extra oxygen to densely packed insulin-secreting cells, enabling long-term treatment for chronic diseases. The system could also potentially provide treatment for other autoimmune diseases.
Researchers at the Salk Institute have identified dozens of microproteins that play a crucial role in regulating fat cell proliferation and lipid accumulation. This breakthrough discovery offers new potential drug targets for treating obesity and metabolic disorders, building on recent advances in CRISPR gene editing technologies.
Younger adults with prediabetes are at increased risk of mortality, highlighting the importance of age-specific interventions and targeted prevention programs. Lifestyle behaviors and limited health care access contribute to this risk, underscoring the need for flexible and accessible diabetes prevention options.
A study reveals faulty genomic regulation and RNA scrambling as key contributors to type-2 diabetes. Deleting HNF1A in β-cells affects the expression of over 100 genes, many involved in insulin transport and release.
A new study found that consuming three servings of French fries weekly increased the risk of developing type 2 diabetes by 20%. In contrast, baked, boiled, or mashed potatoes were not significantly associated with T2D risk. Swapping any form of potato for whole grains may lower the risk of T2D, with a 4% reduction in risk estimated.
A study of over 452,000 adults found that metformin users had significantly lower risks of dementia and all-cause death compared to non-users. The benefits were seen across all categories of overweight and obesity, with reduced risks of up to 26% for death.
A modified version of the DASH diet has been shown to lower glucose levels and improve blood glucose control in adults with type 2 diabetes. The DASH4D diet, which is similar to the original DASH diet but lower in carbohydrates and higher in unsaturated fats, helped participants with type 2 diabetes control their glucose levels.
A landmark study found that adopting five healthy lifestyle habits—healthy weight, no smoking, regular physical activity, high-quality diet, and moderate alcohol intake—can reduce cardiovascular disease risk by up to 86% in women with a history of gestational diabetes. Women who followed all these habits had no cardiovascular events ov...
A new study from University of California San Diego found that frequent standing breaks can lower diastolic blood pressure in postmenopausal women. Women who increased daily sit-to-stand movements saw measurable improvements in blood pressure, with an average decrease of 2.24 mmHg within three months.
A new study found that mothers living in resource-poor neighborhoods in Arizona were 20% more likely to develop gestational diabetes mellitus compared to those in less deprived areas. The study also highlighted the high incidence of GDM among Native Americans, who had a rate nearly double the overall population.
A technology expert predicts AI-based medicine will revolutionise care for Alzheimer’s and diabetes, but access must be made available to all patients. The author highlights key innovations such as diagnostic imaging and surgical robots that will aid in more accurate diagnoses and treatments.
A new AI model uses a combination of data, including real-time glucose levels from wearable monitors, to provide a more nuanced view of diabetes risk. It flags early signs of diabetes risk that standard HbA1c tests may miss.
A UNLV study uses an mRNA cocktail to selectively route to the pancreas, reducing the risk of immune responses and side effects. The breakthrough offers new hope for treating pancreas-related diseases, including cancer and diabetes.
A recent study published in Nature Communications has found that specific cell subtypes are more prone to developing into diabetes. By tracking these subtypes over time, researchers can better understand how they drift over time or under different conditions. The findings hold promise for potential prevention and treatment strategies.
A new study suggests that marbling of fat inside muscles is a strong indicator of poor health, including obesity, Type 2 diabetes, and neuromuscular disorders. The research found that intramuscular fat acts as a physical barrier obstructing muscle healing and regeneration.
The conference will feature keynote speakers Donna Ryan and Erik Wilson, as well as informative presentations and breakout sessions on the latest advances in obesity research. The Louisiana Obesity Society aims to support healthcare providers treating obesity through education and networking.
A recent study published in JAMA Network Open found that glipizide, a commonly used type 2 diabetes medication, is associated with a 13% increase in cardiovascular risk compared to dipeptidyl peptidase-4 (DPP-4) inhibitors. The study analyzed data from nearly 50,000 patients and found that glipizide was linked to higher rates of heart ...
A new study published in The Lancet Public Health found that walking 7000 steps a day offers similar health benefits as walking 10,000 steps. The research analyzed data from 57 studies and found significant improvements in eight major health outcomes, including reduced risk of cardiovascular disease, dementia, and depressive symptoms.
A prospective cohort study found that weekend warriors and regular activity patterns reduced risks for all-cause and cardiovascular mortality among adults with diabetes, demonstrating the importance of any physical activity. The study also compared GLP-1RAs and DPP4is in dementia risk among older adults with diabetes and found no clear...
Researchers have discovered a non-autoimmune form of type 1 diabetes prevalent in young people in Sub-Saharan Africa, differing from the typical autoimmune pattern seen in other regions. The study's findings also suggest an ancestral or genetic link between this subtype and African ancestry in the US.
Research warns that GLP-1 drugs may not provide the long-term health benefit of improved heart and lung function. While they help with weight loss, patients may experience significant muscle loss, which can increase cardiovascular disease risk. Doctors are urging additional research to better understand the effects of these drugs.
Researchers developed a novel nanoconfinement strategy to deliver molecular hydrogen for diabetic bone repair. The innovative implant achieves controlled and sustained H2 release, promoting bone regeneration and neural network formation. This technology addresses key limitations of conventional H2 therapy.
A recent study published in JAMA Network Open found that glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment was associated with reduced all-cause mortality among older patients with cancer and type 2 diabetes. The survival benefit persisted across various subgroups, including age, sex, and cancer type.
Research reveals a direct connection between diabetic peripheral neuropathy and skeletal health, linking nerve damage to reduced cell signaling. The study shows that diabetic mice with nerve damage had weakened bones due to impaired nerve-bone communication.
Researchers at MD Anderson identified specific co-mutations in KRAS-mutant non-small cell lung cancer (NSCLC) that improve treatment response to ATR inhibitors. Additionally, chemotherapy was found to drive changes to the genome and clonal architecture of blood stem cells, increasing the risk of secondary malignancies.
The study found a significant increase in extremely severe obesity among US children and adolescents, leading to severe metabolic and cardiovascular complications. Extremely severe obesity was linked to conditions like metabolic dysfunction-associated steatotic liver disease, prediabetes or diabetes, and metabolic syndrome.
A cohort study found that GLP-1RAs like semaglutide and tirzepatide lower risk of dementia, stroke, and all-cause mortality in adults with type 2 diabetes and obesity. The findings suggest potential neuroprotective benefits beyond glycemic control.
Researchers have discovered a high representation of genes associated with obesity and type 2 diabetes in RNA cargo within extracellular vesicles. The study provides a roadmap for integrating EV transcript profiling with genetic approaches, which could inform the development of novel diagnostic and therapeutic strategies.
Despite supply shortages and insurance coverage obstacles, patients taking GLP-1 medications achieve clinically significant weight loss when paired with intensive lifestyle interventions. The study found that consistent medication courses combined with lifestyle changes and support remain the most effective weight-loss program option.
A new study found that consuming pistachios every night for 12 weeks altered bacteria in the gut of adults with prediabetes, increasing beneficial short-chain fatty acids like butyrate. The changes may offer long-term health benefits, potentially slowing Type 2 diabetes development or reducing inflammation.
A study presented at the Endocrine Society's annual meeting found that socially isolated older adults are 34% more likely to have diabetes and 75% more likely to have poor blood sugar control. Social isolation is being recognized as a critical social determinant of health, highlighting its importance in caring for older patients.
A recent study published by Fujita Health University found that poor oral health can increase the risk of lifestyle-related diseases such as diabetes and heart disease. The researchers examined 118 individuals aged 50 or above and found significant links between oral function test results and blood test results.
Researchers identified TMEM9B-AS1, a long non-coding RNA that regulates cellular functions, as significantly reduced in skeletal muscles of people with type 2 diabetes. Its absence disrupts protein production, leading to muscle weakness and loss.
An international team has uncovered a new mechanism by which mitochondria and peroxisomes work together to defend against oxidative stress, maintaining cellular health. This discovery challenges the long-standing idea that cellular defense is confined within individual compartments.
Researchers at MIT developed an implantable device that can store glucagon to counteract hypoglycemia, a life-threatening condition for people with Type 1 diabetes. The device, about the size of a quarter, contains a small reservoir made of 3D-printed polymer and can be triggered remotely or automatically by a sensor.
A new study found that older people with diabetes who do not control their blood sugar levels are three times more likely to develop eye disease than those with controlled blood sugar levels. High glucose levels were also linked to an increased risk of glaucoma and macular degeneration.
A pilot study evaluated Nutri, a clinical decision support tool for brief diet counseling in safety-net clinics. PCPs found the system usable and satisfactory, while patients effectively engaged with the intervention.
A team of researchers from The University of Osaka has made a breakthrough in weight loss treatment by developing a one-time genome editing approach that introduces a GLP-1 receptor agonist gene. This innovative method enables the body to produce its own weight-loss medication, reducing the need for regular injections.
A study of 679 patients found that longer GLP-1RA treatment, not having diabetes, and higher body fat were associated with better weight reduction. Higher muscle mass and metabolic rate also contributed to successful weight loss in patients with overweight or obesity.
Preliminary research suggests that climate change can lead to a reduction in nutritional quality in food crops, with potential devastating consequences for human health. The study found that elevated CO2 levels and hotter temperatures can exacerbate this decline, particularly affecting essential proteins, minerals, and antioxidants.
A study of 168,547 postmenopausal women found that excess weight is associated with a 31% higher risk of breast cancer in those with cardiovascular disease. Higher BMI also increases the risk in women without cardiovascular disease, although to a lesser extent.
Researchers found significant differences in gut microbiota composition between pregnant women with and without gestational diabetes. A diagnostic model based on genus-level markers showed high precision for early detection of the condition, offering new opportunities for prevention and personalized management.
Researchers at Stanford Medicine discovered that a common signaling pathway protects airways from damage caused by toxins like wildfire smoke or respiratory viruses. The drug, which activates the pathway, protected mice with influenza or COVID-19 infections, while blocking it caused severe damage to their airways.
A study published in the Journal of Epidemiology & Community Health found that a pro-inflammatory diet during pregnancy may raise a child's risk of developing type 1 diabetes. The research, which followed pregnant women from Denmark, found a 16% increase in risk for each unit increase in dietary measure of inflammatory food intake.